Literature DB >> 6134545

Ranitidine and testosterone secretion in man.

V Savarino, M Giusti, C Mansi, M Marugo, G Delitala, G Celle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134545      PMCID: PMC1427707          DOI: 10.1111/j.1365-2125.1983.tb02098.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones.

Authors:  R P Walt; S J LaBrooy; A Avgerinos; T Oehr; A Riley; J J Misiewicz
Journal:  Scand J Gastroenterol Suppl       Date:  1981-06

2.  Effect of cimetidine on gonadal function in man.

Authors:  C Wang; C L Lai; K C Lam; K K Yeung
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

3.  Clinical and endocrine aspects of treatment with ranitidine.

Authors:  E J Boyd; N R Peden; M C Browning; J H Saunders; K G Wormsley
Journal:  Scand J Gastroenterol Suppl       Date:  1981-06

4.  Effects of two histamine H2-receptor blocking drugs on basal levels of gonadotrophins, prolactin, testosterone and oestradiol-17 beta during treatment of duodenal ulcer in male patients.

Authors:  N R Peden; E J Boyd; M C Browning; J H Saunders; K G Wormsley
Journal:  Acta Endocrinol (Copenh)       Date:  1981-04

5.  Cimetidine, a histamine H2 receptor antagonist, occupies androgen receptors.

Authors:  J W Funder; J E Mercer
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

6.  Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine.

Authors:  D H Van Thiel; J S Gavaler; W I Smith; G Paul
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

  6 in total
  1 in total

Review 1.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.